Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/2005

01-01-2005

Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer

Authors: Hidetaka A. Ono, Julia G. Davydova, Yasuo Adachi, Koichi Takayama, Shannon D. Barker, Paul N. Reynolds, Victor N. Krasnykh, Chikara Kunisaki, Hiroshi Shimada, David T. Curiel, Masato Yamamoto

Published in: Journal of Gastroenterology | Issue 1/2005

Login to get access
Metadata
Title
Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer
Authors
Hidetaka A. Ono
Julia G. Davydova
Yasuo Adachi
Koichi Takayama
Shannon D. Barker
Paul N. Reynolds
Victor N. Krasnykh
Chikara Kunisaki
Hiroshi Shimada
David T. Curiel
Masato Yamamoto
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 1/2005
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-004-1490-y

Other articles of this Issue 1/2005

Journal of Gastroenterology 1/2005 Go to the issue

Letters to the editor

Two cases of acute necrotizing pancreatitis complicating after transcatheter arterial embolization for hepatocellular carcinoma

OriginalPaper

MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis

OriginalPaper

Abnormal acid reflux in asthmatic patients in a region with low GERD prevalence

OriginalPaper

Defense mechanisms in inflammatory bowel disease

Case report

A case of leptomeningeal carcinomatosis from esophageal basaloid carcinoma diagnosed by quantitative reverse transcription-polymerase chain reaction for carcinoembryonic antigen

OriginalPaper

Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits